IL102612A - History of Hydroxylamine Transformed by Troaril, Preparation and Pharmaceutical Preparations Containing Them - Google Patents
History of Hydroxylamine Transformed by Troaril, Preparation and Pharmaceutical Preparations Containing ThemInfo
- Publication number
- IL102612A IL102612A IL10261292A IL10261292A IL102612A IL 102612 A IL102612 A IL 102612A IL 10261292 A IL10261292 A IL 10261292A IL 10261292 A IL10261292 A IL 10261292A IL 102612 A IL102612 A IL 102612A
- Authority
- IL
- Israel
- Prior art keywords
- carbocyclic
- lower alkyl
- alkyl
- aryl
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73807591A | 1991-07-30 | 1991-07-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL102612A0 IL102612A0 (en) | 1993-01-14 |
IL102612A true IL102612A (en) | 1996-11-14 |
Family
ID=24966464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10261292A IL102612A (en) | 1991-07-30 | 1992-07-23 | History of Hydroxylamine Transformed by Troaril, Preparation and Pharmaceutical Preparations Containing Them |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0526402B1 (zh) |
JP (1) | JPH0641104A (zh) |
KR (1) | KR930002329A (zh) |
AT (1) | ATE162525T1 (zh) |
AU (1) | AU662339B2 (zh) |
CA (1) | CA2074797A1 (zh) |
CZ (1) | CZ235192A3 (zh) |
DE (1) | DE69224115T2 (zh) |
DK (1) | DK0526402T3 (zh) |
ES (1) | ES2111059T3 (zh) |
FI (1) | FI923393A (zh) |
GR (1) | GR3026254T3 (zh) |
HU (1) | HUT66626A (zh) |
IE (1) | IE922471A1 (zh) |
IL (1) | IL102612A (zh) |
MX (1) | MX9204418A (zh) |
NO (1) | NO178925C (zh) |
NZ (1) | NZ243752A (zh) |
PH (1) | PH30092A (zh) |
TW (1) | TW281672B (zh) |
ZA (1) | ZA925688B (zh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6642268B2 (en) | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
US6262277B1 (en) | 1994-09-13 | 2001-07-17 | G.D. Searle And Company | Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
US6268392B1 (en) | 1994-09-13 | 2001-07-31 | G. D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
US5516789A (en) * | 1995-04-12 | 1996-05-14 | Abbott Laboratories | Lipoxygenase and cyclooxygenase inhibiting compounds |
BE1010487A6 (nl) | 1996-06-11 | 1998-10-06 | Unilin Beheer Bv | Vloerbekleding bestaande uit harde vloerpanelen en werkwijze voor het vervaardigen van dergelijke vloerpanelen. |
CN1342090A (zh) | 1998-12-23 | 2002-03-27 | G·D·瑟尔有限公司 | 适用于心血管疾病的回肠胆汁酸转运抑制剂和贝酸衍生物的组合 |
JP2002533414A (ja) | 1998-12-23 | 2002-10-08 | ジー.ディー.サール エルエルシー | 心臓血管に適用するための回腸胆汁酸輸送阻害剤および胆汁酸隔離剤の組み合わせ |
EP1340510A1 (en) | 1998-12-23 | 2003-09-03 | G.D. Searle LLC. | Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications |
PL348508A1 (en) | 1998-12-23 | 2002-05-20 | Searle Llc | Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications |
US6462091B1 (en) | 1998-12-23 | 2002-10-08 | G.D. Searle & Co. | Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications |
KR20010099937A (ko) | 1998-12-23 | 2001-11-09 | 윌리암스 로저 에이 | 심혈관 징후용 콜레스테릴 에스테르 전달 단백질 억제제및 피브르산 유도체의 조합물 |
JP2002533408A (ja) | 1998-12-23 | 2002-10-08 | ジー.ディー.サール エルエルシー | 心臓血管に適用するためのコレステリルエステル転送タンパク質阻害剤およびニコチン酸誘導体の組み合わせ |
EP1286984A2 (en) | 2000-03-10 | 2003-03-05 | Pharmacia Corporation | Method for the preparation of tetrahydrobenzothiepines |
DE10103506A1 (de) * | 2001-01-26 | 2002-08-14 | Ingo S Neu | Pharmazeutische Zusammensetzung zur Behandlung von Multiple Sklerose |
EP1448546A4 (en) | 2001-11-02 | 2005-02-02 | Searle Llc | MONO- AND DI-FLUORINATED BENZOTHIEPINE COMPOUNDS AS INHIBITORS OF TRANSPORT OF ACIDICALLY DEPENDENT SODIUM ACILIC (ASBT) BILIARY ACIDS AND TAUROCHOLATE RECOVERY |
JP2005521653A (ja) | 2002-01-17 | 2005-07-21 | ファルマシア コーポレイション | 先端ナトリウム同時依存性胆汁酸輸送(asbt)およびタウロコール酸塩取込みの阻害剤としての新規アルキル/アリールヒドロキシまたはケトチエピン化合物 |
DE10229762A1 (de) * | 2002-07-03 | 2004-01-22 | Aventis Pharma Deutschland Gmbh | Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase |
US7265131B2 (en) | 2002-12-20 | 2007-09-04 | Exelixis, Inc. | Isoquinolinone derivatives and their use as therapeutic agents |
EP3509587B1 (en) | 2016-09-12 | 2023-12-06 | Valo Health, Inc. | Monocyclic compounds useful as gpr120 modulators |
JP7065081B2 (ja) * | 2016-09-12 | 2022-05-11 | インテグラル ヘルス, インコーポレイテッド | Gpr120モジュレーターとして有用な二環式化合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI89709C (fi) * | 1985-03-16 | 1993-11-10 | Wellcome Found | Foerfarande foer framstaellning av terapeutiskt anvaendbara arylderivat |
US4761403A (en) * | 1986-04-09 | 1988-08-02 | Abbott Laboratories | Lipoxygenase inhibiting compounds |
DE3882732T2 (de) * | 1987-02-10 | 1993-12-02 | Abbott Lab | Indol, Benzofuran, Benzothiophen enthaltende, Lipoxygenase hemmende Verbindungen. |
US4981865A (en) * | 1989-05-26 | 1991-01-01 | Warner-Lambert Co. | N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents |
-
1992
- 1992-07-21 EP EP92810559A patent/EP0526402B1/en not_active Expired - Lifetime
- 1992-07-21 ES ES92810559T patent/ES2111059T3/es not_active Expired - Lifetime
- 1992-07-21 DE DE69224115T patent/DE69224115T2/de not_active Expired - Fee Related
- 1992-07-21 DK DK92810559T patent/DK0526402T3/da active
- 1992-07-21 AT AT92810559T patent/ATE162525T1/de not_active IP Right Cessation
- 1992-07-22 AU AU20482/92A patent/AU662339B2/en not_active Ceased
- 1992-07-23 IL IL10261292A patent/IL102612A/en not_active IP Right Cessation
- 1992-07-24 PH PH44703A patent/PH30092A/en unknown
- 1992-07-24 TW TW081105850A patent/TW281672B/zh active
- 1992-07-27 CZ CS922351A patent/CZ235192A3/cs unknown
- 1992-07-27 FI FI923393A patent/FI923393A/fi not_active Application Discontinuation
- 1992-07-28 JP JP4201496A patent/JPH0641104A/ja active Pending
- 1992-07-28 NZ NZ243752A patent/NZ243752A/en unknown
- 1992-07-28 CA CA002074797A patent/CA2074797A1/en not_active Abandoned
- 1992-07-29 ZA ZA925688A patent/ZA925688B/xx unknown
- 1992-07-29 MX MX9204418A patent/MX9204418A/es unknown
- 1992-07-29 IE IE247192A patent/IE922471A1/en not_active Application Discontinuation
- 1992-07-29 NO NO922987A patent/NO178925C/no unknown
- 1992-07-29 KR KR1019920013541A patent/KR930002329A/ko active IP Right Grant
- 1992-07-29 HU HU9202479A patent/HUT66626A/hu unknown
-
1998
- 1998-02-27 GR GR980400432T patent/GR3026254T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69224115D1 (de) | 1998-02-26 |
CA2074797A1 (en) | 1993-01-31 |
EP0526402B1 (en) | 1998-01-21 |
IE922471A1 (en) | 1993-02-10 |
NO178925C (no) | 1996-07-03 |
NO922987D0 (no) | 1992-07-29 |
ES2111059T3 (es) | 1998-03-01 |
AU662339B2 (en) | 1995-08-31 |
HU9202479D0 (en) | 1992-10-28 |
DK0526402T3 (da) | 1998-09-14 |
NO178925B (no) | 1996-03-25 |
KR930002329A (ko) | 1993-02-23 |
IL102612A0 (en) | 1993-01-14 |
TW281672B (zh) | 1996-07-21 |
FI923393A0 (fi) | 1992-07-27 |
EP0526402A1 (en) | 1993-02-03 |
GR3026254T3 (en) | 1998-05-29 |
FI923393A (fi) | 1993-01-31 |
DE69224115T2 (de) | 1998-08-20 |
ATE162525T1 (de) | 1998-02-15 |
NO922987L (no) | 1993-02-01 |
JPH0641104A (ja) | 1994-02-15 |
AU2048292A (en) | 1993-02-04 |
PH30092A (en) | 1996-12-27 |
MX9204418A (es) | 1993-02-01 |
ZA925688B (en) | 1993-03-31 |
HUT66626A (en) | 1994-12-28 |
NZ243752A (en) | 1994-09-27 |
CZ235192A3 (en) | 1993-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5260316A (en) | Isoquinolyl substituted hydroxylamine derivatives | |
US5350761A (en) | Indolyl substituted hydroxylamine derivatives | |
US5334600A (en) | Isoquinolyl substituted hydroxylamine derivatives | |
EP0526402B1 (en) | Heteroaryl substituted hydroxylamine derivatives as lipoxygenase inhibitors | |
US5120758A (en) | Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors | |
AU779117B2 (en) | Protease inhibitors | |
AU2002231097B2 (en) | Piperidine MCH antagonists and their use in the treatment of obesity | |
US6239143B1 (en) | 5-HT7 receptor antagonists | |
KR100274367B1 (ko) | 흥분성 아미노산 수용체 길항물질 | |
JPH11349586A (ja) | 新規なベンゾチオフェン、ベンゾフランおよびインド―ル化合物、それらの製造法およびそれらを含む医薬組成物 | |
IE902908A1 (en) | Certain benzopyran and benzothiopyran derivatives | |
CZ304003B6 (cs) | Benzofuranové a benzothiofenové deriváty, zpusob jejich prípravy, lécivo a farmaceutická a veterinární kompozice tyto deriváty obsahující a pouzití techto derivátu k príprave léciva | |
WO2000007993A1 (en) | Substituted isoquinoleines and their use as anticonvulsivants | |
Zamboni et al. | Development of a novel series of styrylquinoline compounds as high-affinity leukotriene D4 receptor antagonists: synthetic and structure-activity studies leading to the discovery of (.+-.)-3-[[[3-[2-(7-chloro-2-quinolinyl)-(E)-ethenyl] phenyl][[3-(dimethylamino)-3-oxopropyl] thio] methyl] thio] propionic acid | |
JP5140226B2 (ja) | アミノアルコキシベンゾイル−ベンゾフランまたはベンゾチオフェン誘導体、その製造方法およびそれを含む組成物 | |
CZ416498A3 (cs) | Substituovaný benzamidový derivát a jeho použití jako antikonvulsantu | |
JPWO2004009556A1 (ja) | 4−置換アリール−5−ヒドロキシイソキノリノン誘導体 | |
US5155130A (en) | Certain benzopyran and benzothiopyran derivatives | |
JP4153574B2 (ja) | 新規なピペリジン誘導体、その製造法およびそれを含有する循環器官用剤 | |
WO2001062733A1 (en) | Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors | |
MXPA01006070A (en) | (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
HC | Change of name of proprietor(s) | ||
RH | Patent void |